BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21387408)

  • 1. Introduction of a disulfide bond leads to stabilization and crystallization of a ricin immunogen.
    Compton JR; Legler PM; Clingan BV; Olson MA; Millard CB
    Proteins; 2011 Apr; 79(4):1048-60. PubMed ID: 21387408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the putative vascular leak peptide sequence in the stabilized ricin vaccine candidate RTA1-33/44-198.
    Janosi L; Compton JR; Legler PM; Steele KE; Davis JM; Matyas GR; Millard CB
    Toxins (Basel); 2013 Jan; 5(2):224-48. PubMed ID: 23364220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Introduction of a disulfide bond into ricin A chain decreases the cytotoxicity of the ricin holotoxin.
    Argent RH; Roberts LM; Wales R; Robertus JD; Lord JM
    J Biol Chem; 1994 Oct; 269(43):26705-10. PubMed ID: 7929403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies.
    Legler PM; Compton JR; Hale ML; Anderson GP; Olson MA; Millard CB; Goldman ER
    MAbs; 2017 Jan; 9(1):43-57. PubMed ID: 27660893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutralizing monoclonal antibodies against ricin's enzymatic subunit interfere with protein disulfide isomerase-mediated reduction of ricin holotoxin in vitro.
    O'Hara JM; Mantis NJ
    J Immunol Methods; 2013 Sep; 395(1-2):71-8. PubMed ID: 23774033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of RiVax: a recombinant ricin vaccine.
    Legler PM; Brey RN; Smallshaw JE; Vitetta ES; Millard CB
    Acta Crystallogr D Biol Crystallogr; 2011 Sep; 67(Pt 9):826-30. PubMed ID: 21904036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of non-linear neutralizing B cell epitopes on ricin toxin's enzymatic subunit (RTA).
    O'Hara JM; Kasten-Jolly JC; Reynolds CE; Mantis NJ
    Immunol Lett; 2014; 158(1-2):7-13. PubMed ID: 24269767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finding a new vaccine in the ricin protein fold.
    Olson MA; Carra JH; Roxas-Duncan V; Wannemacher RW; Smith LA; Millard CB
    Protein Eng Des Sel; 2004 Apr; 17(4):391-7. PubMed ID: 15187223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monoclonal immunoglobulin G antibody directed against an immunodominant linear epitope on the ricin A chain confers systemic and mucosal immunity to ricin.
    Neal LM; O'Hara J; Brey RN; Mantis NJ
    Infect Immun; 2010 Jan; 78(1):552-61. PubMed ID: 19858297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection.
    Roy CJ; Brey RN; Mantis NJ; Mapes K; Pop IV; Pop LM; Ruback S; Killeen SZ; Doyle-Meyers L; Vinet-Oliphant HS; Didier PJ; Vitetta ES
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):3782-7. PubMed ID: 25775591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents.
    Woo BH; Lee JT; Park MO; Lee KR; Han JW; Park ES; Yoo SD; Lee KC
    Arch Pharm Res; 1999 Oct; 22(5):459-63. PubMed ID: 10549572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steered unfolding of ricin A and B chains.
    Ganguly D; Mukhopadhyay C
    J Mol Graph Model; 2008 Oct; 27(3):266-74. PubMed ID: 18565774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and mutational analysis of a monomeric and dimeric form of a single domain antibody with implications for protein misfolding.
    George J; Compton JR; Leary DH; Olson MA; Legler PM
    Proteins; 2014 Nov; 82(11):3101-16. PubMed ID: 25136772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ricin toxin contains at least three galactose-binding sites located in B chain subdomains 1 alpha, 1 beta, and 2 gamma.
    Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham MC
    Biochemistry; 1996 Nov; 35(47):14749-56. PubMed ID: 8942636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural analysis of nested neutralizing and non-neutralizing B cell epitopes on ricin toxin's enzymatic subunit.
    Rudolph MJ; Vance DJ; Cassidy MS; Rong Y; Shoemaker CB; Mantis NJ
    Proteins; 2016 Aug; 84(8):1162-72. PubMed ID: 27159829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Analysis of Single Domain Antibodies Bound to a Second Neutralizing Hot Spot on Ricin Toxin's Enzymatic Subunit.
    Rudolph MJ; Vance DJ; Cassidy MS; Rong Y; Mantis NJ
    J Biol Chem; 2017 Jan; 292(3):872-883. PubMed ID: 27903650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic effects of ricin without an interchain disulfide bond: genetic modification and chemical crosslinking studies.
    Mohanraj D; Ramakrishnan S
    Biochim Biophys Acta; 1995 Apr; 1243(3):399-406. PubMed ID: 7727515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-domain antibodies neutralize ricin toxin intracellularly by blocking access to ribosomal P-stalk proteins.
    Czajka TF; Vance DJ; Davis S; Rudolph MJ; Mantis NJ
    J Biol Chem; 2022 Apr; 298(4):101742. PubMed ID: 35182523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folding domains within the ricin toxin A subunit as targets of protective antibodies.
    O'Hara JM; Neal LM; McCarthy EA; Kasten-Jolly JA; Brey RN; Mantis NJ
    Vaccine; 2010 Oct; 28(43):7035-46. PubMed ID: 20727394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of an unusual CDR2 element of a single domain antibody in ricin toxin binding affinity and neutralizing activity.
    Rudolph MJ; Vance DJ; Kelow S; Angalakurthi SK; Nguyen S; Davis SA; Rong Y; Middaugh CR; Weis DD; Dunbrack R; Karanicolas J; Mantis NJ
    Protein Eng Des Sel; 2018 Jul; 31(7-8):277-287. PubMed ID: 30265352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.